Karim joined Amzak Health in 2022 and focuses on Medical Devices & Digital Health. Karim comes to Amzak with over 15 years of industry experience in Life Sciences across multiple sectors and functional areas.

Prior to Amzak, Karim was at Merck where he led commercial business development for diagnostics as well as established and managed the Digital & AI-based Diagnostics commercial portfolio in Oncology. Prior to Merck Oncology, Karim led Corporate Strategy for Merck’s Animal Health division where he formulated long-term strategy and supported large-scale M&A . Prior to Merck, Karim was at Denstply-Sirona where he worked in both Business Development and R&D. Karim began his career as an R&D Engineer at Becton & Dickinson.

Karim holds a BS and MS in Biomedical Engineering from the New Jersey Institute of Technology and an MBA with Honors from Columbia Business School.